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Abstract
Background Although cytosolic DNA degradation plays an important role in
decreasing transgene expression, the plasmid degradation pattern remains
largely unexplored.
Methods Illumina dye sequencing was employed to provide degradation site
information for S1 and cytosolic nucleases. S1 nuclease provided a positive
control for a comparison between the agarose gel method and sequencing
approaches.
Results The poly(A) region between the β-lactamase gene and the cytomeg-
alovirus (CMV) promoter was identiﬁed as the most likely cut site for polyplex-
treated cytosol. The second most likely site, at the 5’ end of the β-lactamase
gene, was identiﬁed by gel electrophoresis and sequencing. Additional sites
were detected in the OriC region, the SV40/poly(A) region, the luciferase gene
and the CMV promoter. Sequence analysis of plasmid treated with cytosol from
control cells showed the greatest cut activity in the OriC region, the β-
lactamase gene and the poly(A) region following the luciferase gene. Addi-
tional regions of cut activity include the SV40 promoter and the β-lactamase
poly(A) termination sequence. Both cytosolic nucleases and the S1 nuclease
showed substantial activity at the bacterial origin of replication (OriC).
Conclusions High-throughput plasmid sequencing revealed regions of the
luciferase plasmid DNA sequence that are sensitive to cytosolic nuclease degra-
dation. This provides new targets for improving plasmid and/or polymer
design to optimize the likelihood of protein expression. Copyright © 2014 John
Wiley & Sons, Ltd.
Keywords biotechnology; HeLa; plasmid design; plasmid gene delivery; polymer
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Introduction
Antisense DNA, silencing RNA and plasmid DNA (pDNA) remain promising
therapeutics with possible applications including diagnosis, vaccines, and
disease management [1]. The range of applications and potential impact on
common, life-threatening diseases such as diabetes mellitus and metastatic
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neoplasm [1] led to a predicted pharmaceutical industry
of $16.8 billion/year by 2020–2025 [2]; however, almost
15 years after this prediction, gene therapy is only a small
fraction of this multibillion dollar market projection. This
lack of market availability and penetration arises primar-
ily because of safety and efﬁciency issues for current
nucleic acid delivery systems [3,4]. The development of
nonviral delivery systems such as polycationic polymers
presents a unique and unprecedented opportunity to ge-
netic engineers [5,6]. Polymers allow a signiﬁcant amount
of customization, provide a high surface moiety to volume
ratio and are relatively safe compared to viral systems
[7,8]; however, they still have the major drawback of
low transgene expression. Incomplete understanding of
cellular uptake mechanisms [9,10], inefﬁcient endosomal
escape [11–13] and poorly designed and understood nu-
clear uptake [13,14] are considered to be the major reasons
limiting optimization [3,13].
Recent work by Lechardaur et al. [15] and Pollard et al.
[16] demonstrates that cyotosolic nucleases play a signif-
icant role in limiting expression efﬁciency. Our recent
work has shown that differential transgene expression fa-
cilitated by jetPEI™ (Polyplus-transfection Inc., New York,
NY, USA), linear poly(ethylenimine) and generation 5
poly(amidoamine) (G5 PAMAM) dendrimer can be
explained by the activation of cytosolic nucleases that de-
grade the plasmid into a nonfunctional form [17]. Charac-
terizing the activity pattern of these cytosolic nucleases is
a key step in the development of better synthetic strate-
gies for polymers capable of delivering, protecting and
releasing the plasmid. Substantial efforts have been
expended to make the plasmid less susceptible to nuclease
degradation via backbone, codon and poly(A) modiﬁca-
tions and by removing viral DNA components [18,19].
In the present study, high-throughput sequencing is
used to identify and quantify labile sites on a pGL4.51
luciferase expressing plasmid that is susceptible to cyto-
solic nucleases. S1 nuclease was used both to validate
the experimental protocols and to develop a comparison
with the published cleavage pattern determined using
agarose gel electrophoresis [18,19]. High-throughput
sequencing not only identiﬁes more labile sites than
previously observed using agarose gel electrophoresis,
but also provides information about the relative degree
of degradation per site and substantially greater resolu-
tion of the site location in the plasmid sequence. Many
of the cleavage sensitive sequences lay in homopurine
and homopyrimidine regions of the synthetic/viral poly
(A) regions and the plasmid’s bacterial origin of replica-
tion (OriC); however, labile sites were also identiﬁed in
the reporter and antibiotic resistance genes required for
stable expression [20]. Many of the labile sites identiﬁed
in the plasmid correspond to regions that are indispensible
for plasmid functionality.
Human epithelial carcinoma cells (HeLa cells) were
used based on previous studies exploring the role of cyto-
solic nucleases [15,18]. S1 nuclease was used as the con-
trol nuclease because it has been shown that customizing
plasmid sequences on the basis of S1 nuclease activity can
improve plasmid stability [18,19]. The luciferase expres-
sion plasmid was selected because it is widely used in
gene expression studies in mammalian cells and under-
standing the susceptibility to cytosolic nucleases should
be useful for a broad range of research groups. The
plasmid also contains the commonly employed selective
Neomycin gene to select for permanently transgene ex-
pressing mammalian cells.
Materials and methods
Protocol for obtaining cell cytosol
HeLa cells (catalogue #CCL-2) were obtained from
American Type Culture Collection (ATCC, Manassas, VA,
USA). S1 nuclease and 10×S1 nuclease buffer, salmon
sperm DNA (ssDNA) and luciferase plasmid (pGL4.51)
were purchased from Promega Corp. (Madison, WI, USA).
A circular map of the plasmid is provided in the Supporting
information (Figure S1). The Serum free media (SFM)
employed in the present study was minimal essential media
(MEM) with glutamine and Earle salts obtained from Life
Technologies (Life Technologies, Grand Island, NY, USA).
Complete media was made by adding 50ml of fetal bovine
serum and 5ml of 100×penicillin-streptomycin to 500ml
of MEM. The BCA protein assay kit was purchased from
Thermo Fisher Scientiﬁc, Inc. (Waltham, MA, USA).
PAMAM dendrimer was purchased from Dendritech, Inc.
(Midland, MI, USA). In-house characterization revealed a
molecular weight of 28 900 and a polydispersity index of
1.01. Titration showed 116 amines per dendrimer.
For transfection and cytosol extraction, 500 000 HeLa
cells/well were cultured in a six-well plate with 1.5ml of
complete media at 37°C overnight. Subsequently, cells
were treated in duplicate with a 10:1 nitrogen to phospho-
rus ratio of G5 PAMAM polyplexes (2 μg of ssDNA,
15.13μg of G5 PAMAM, 100μl of water) for 3 h in 0.9ml
of SFM. After 3 h, the transfection media was replaced
with 1.5ml of complete media and the cells were incu-
bated for another 1 h. Cells were then washed with phos-
phate-buffered saline (PBS) without Ca2+ and Mg2+ and
incubated with 200μl of 0.1% trypsin for 5min at 37°C.
Then, 1.8ml of cold PBS (4°C) with Ca2+ and Mg2+ ions
was added to each well to stop trypsin activity. Dupli-
cates were pooled together and cells were centrifuged
at 200 g. To obtain cell lysates, the cell pellet was
suspended in 200 μl of ice-cold cell lysis buffer and
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incubated for 30min on ice. Afterwards, the samples
were centrifuged at 500 g. for 5min at 4°C and the super-
natants were collected. A BCA assay was used to assess
and normalize protein concentration in subsequent
experiments. The control lysates from nontreated cells
were prepared identically, except that no polyplexes
were added in the initial step.
Sequencing and gel protocols
NP-40 lysis buffer was procured from Boston BioProducts
Inc. (Worcester, MA, USA), protease inhibitor cocktail was
obtained from Sigma-Aldrich (St Louis, MO, USA). The
Gel extraction kit was purchased from Qiagen (Valencia,
CA, USA) (catalogue number 28706) and used as
directed. 10×BlueJuice™ gel loading buffer was obtained
from Life Technologies Corp. (catalogue number 0816–
015). Three restriction endonucleases, SacI (catalogue
number R3156S), DraIII (catalogue number R3510S)
and StuI (catalogue number R0187S), were obtained from
New England BioLabs, Inc. (Beverly, MA, USA). Nb.BtsI
(catalogue number R0707S) and Nt.CviPII (catalogue
number R0626S) were obtained from New England
BioLabs Inc. An Illumina HiSeq 2000 (Illumina, Inc., San
Diego, CA, USA) was employed for all sequencing experi-
ments. Initial sequence alignment was completed with the
help of BOWTIE (http://bowtie-bio.sourceforge.net/in-
dex.shtml). Integrated Genomic Viewer (http://www.
broadinstitute.org/igv/) was used to view the aligned
sequence. MATLAB™ (MathWorks, Natick, MA, USA)
was employed to generate heat-maps of nuclease activity.
The heat map cut ratios were obtained by normalizing
each base readcount by the average readcount for that
sample and then dividing by the normalized readcount
from the untreated DNA control.
Protocol for treating Luciferase pDNA
with cell cytosol
In total, 20μg of pDNA was incubated with 10μg of the
isolated cytosol in 100μl of water for 30min at 37°C. S1
nuclease cleavage sample were prepared by adding 10
units of S1 nuclease to 20μg of pDNA in 100 μl of water
and 1×S1 nuclease buffer for 30min at 37°C. The
negative control was prepared using 20 μg of pDNA re-
suspended in 100μl of water and employed using the
same incubation conditions.
For Illumina dye sequencing, samples containing 100μl
of the plasmid reaction mixture were treated with cell
extracts (polyplex-treated cells or untreated cells) or S1
nuclease and optimized using the Qiagen gel extraction
kit (the 100 μl of reaction mixture was used in place of
excised gel) to change the buffering media to 10mM
Tris-Cl at pH 8.5 for downstream sequencing. In addition,
a plasmid-only control was brought through the identical
procedure.
For agarose gel electrophoresis, 10μl of the plasmid re-
action mixtures described above were added to each well
in 1×BlueJuice™ gel loading buffer. The gel electrophore-
sis was performed on a 0.9% agarose gel containing
ethidium bromide at 60V for 3 h.
For the restriction nuclease analysis, agarose gel
electrophoresis was performed using 10μl of the S1
nuclease and luciferase plasmid reaction mixture in 10
parallel lanes (under the conditions used for this mixture
in Figure 1, lane 5). The linear topology 6.4-kb form of the
luciferase plasmid was then cut out from gel and puriﬁed
using a Qiagen gel extraction kit. Next, 0.2 μg of the
isolated 6.4-kb linear plasmid was incubated with either
2 units of SacI, DraIII or StuI restriction endonucleases
in the supplied reaction buffer for 60min at 37°C. Control
digests were performed with these restriction endonucle-
ases and using the luciferase plasmid under same condi-
tions. SacI, DraIII and StuI endonucleases were used
because they each have a single restriction site in the
plasmid sequence, which provides sufﬁcient resolution to
map the pDNA. The endonuclease treated samples were
analyzed on 0.9% agarose gel containing ethidium bro-
mide at 60 V for 3 h.
Figure 1. Agarose gel electrophoresis showing the DNA cleavage
pattern of HeLa cytosol and S1 nuclease treated luciferase pDNA.
Lanes 1 and 8: 10-kb DNA ladder. Lane 2: pDNA in water. Lane 3:
pDNA treated with cells only cytosol in water. Lane 4: pDNA
treated with cytosol in water from cells exposed to G5 polyplexes.
Lane 5: pDNA treatedwith S1 nuclease in S1 nuclease buffer. Lane
6: pDNA treated with S1 nuclease in water. In lanes 3–6, both the
nicked and linear topology of the plasmid can be seen.
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Results and Discussion
Cleavage sites as determined by agarose
gel electrophoresis
The degradation pattern resulting from treatment of lucif-
erase plasmid with S1 nuclease or the nucleases present
in cytosol was ﬁrst studied using agarose gel electrophore-
sis. Figure 1 illustrates that upon treatment with either S1
or cytosolic nucleases the supercoiled pDNA degrades into
two major forms, a linear plasmid of 6.4 kb and nicked
plasmids appearing as approximately 10-kb fragments
compared to the linear DNA size ladder (Figure S2). The
gel also shows substantial streaking, suggesting the pres-
ence of other sites susceptible to nuclease cleavage. The
major band of the 6.4-kb linear plasmid was extracted
from the gel and incubated with either Sac1, DraIII or StuI
endonucleases (Figure 2). These three restriction endonu-
cleases, which cut at the 735, 2006 and 3212-bp sites, re-
spectively, provide the redundancy necessary to deﬁne the
primary S1 cut site. The pattern obtained with all three
endonucleases indicated a S1 cut site located at the
5000±500 bp position of the pDNA. This site is close to
the homopurine/homopyrimidine rich plasmid OriC
region, consistent with previous work that showed
homopurine regions are susceptible to S1 nuclease
degradation [19]. In previous work, both the poly(A)
and OriC regions were noted to be ‘hot spots’ for S1
cleavage [19].
The analysis presented in Figures 1 and 2 provides a
useful start for understanding nuclease activity against
plasmids in cells; however, two aspects of the experiment
could beneﬁt from substantial improvement. First, the
inherent resolution of the gel electrophoresis method (ap-
proximately 500 bp) prevents a detailed sequence deter-
mination of where the pDNA was cut. This limits the
extent to which one can understand the S1 and cytosolic
nuclease activity and make comparisons between them.
Second, it appeared unlikely, particularly giving the
streaking in Figure 1, that a single cleavage sequence
existed for either cytosolic nucleases or the S1 nuclease,
suggesting that the gels did not have the desired level of
sensitivity. In addition to these concerns, Sanger sequenc-
ing is limited by the choice of primers. Given this set of
concerns and challenges, the high-throughput Illumina
dye sequencing method was employed to explore the
range of cellular nuclease cuts introduced on the pDNA
[21]. We employed S1 nuclease as both a positive control,
in comparison with the gel work, and to learn more about
the S1 activity. There are number of advantages to using
high-throughput Illumina dye sequencing for the cytosolic
nuclease experiments. The development of speciﬁc se-
quencing primer sets, as well as the need to perform mul-
tiple gels for the analysis of restriction enzyme patterns
for each cut site of interest, is avoided (as illustrated in
Figure 2). In addition, the high-throughput sequencing
also provides higher resolution of the cut site location.
Lastly, high-throughput sequencing deﬁnes the degree of
cutting over a region (vida infra), as opposed to the notion
of a singular base pair location. This observation is impor-
tant both for design of more robust plasmids and for the
design of polymers that might protect these regions.
Cleavage sites as determined by
high-throughput sequencing
High-throughput Illumina dye sequencing was performed
in three steps [21]. The ﬁrst step was library preparation
where the treated and control luciferase pDNA samples
were randomly broken into smaller fragments with
sonication, adenylated, connected to adapter oligonucleo-
tides, size-selected and puriﬁed. Next, the materials
underwent cluster generation where each library of
fragments was clonally ampliﬁed. The ﬁnal step was
sequencing, which was performed for each cluster in par-
allel, using ﬂuorescent deoxyribonucleotides.
Heat maps illlustrate both the location and extent of
nuclease cut on the luciferase pDNA. Figures 3A, 4A,
and 4D illustrate the full set of data. Figures 3B, 4B,
Figure 2. Endonuclease treatment of 6.4-kb linear plasmid (LP).
Lanes 1 and 10: 10-kb DNA ladder. Lane 2: pDNA in water. Lane
3: LP in water. Lanes 4, 6 and 8: pDNA treated with SacI, DraIII
and StuI, respectively. Lanes 5, 7 and 9: LP treated with SacI,
DraIII and StuI, respectively. The 6.4-kb LP is derived from treat-
ment of luciferase pDNA with S1 nuclease.
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and 4E focus on approximately the top 15 cut regions.
Figures 3C, 4C, and 4F focus on the top 3–5 cut regions
for easiest comparison with the agarose gel electropho-
resis data. At the bottom of Figures 3 and 4, a
luciferase gene functional map is provided in registry
with the heat map to facilitate comparison of cut sites
with the different regions of the pDNA plasmid. A black
line indicates a cut extent equal to the highest value of
the range. White regions indicate a cut frequency lower
than or equal to the lowest value of the speciﬁed range.
The greyscale vertical lines indicate the percentage of
plasmids cut at that location.
The heat map in Figure 3 illustrates S1 nuclease activity
on luciferase pDNA in water. Figure 3A indicates the loca-
tions where 0–45% of the plasmids were cut. There are
few ‘white’ regions corresponding to sequences where no
cuts were detected, indicating that the nuclease is promis-
cuous with respect to the types of base sequences suitable
for a cleavage location. Figure 3B illustrates only sites in
which 25–45% of the plasmids were cleaved and
Figure 3C illustrates sites in which only 28–45% of the
plasmids were cleaved. Information regarding each cut
site, including percentage ATcontent, function of the plas-
mid region, cut location and width, and fraction of plas-
mids cut is summarized in Table 1 for the top 15 regions
(Figure 3B). These regions include four cuts (S1–4) in the lu-
ciferase gene, a cut in the SV40 promoter/enhancer (S5),
cuts in three locations on the Neomycin gene (S6–8), cuts
at three sites on the origin of replication region (S9–11)
and three cut sites on ampicillin gene (S13–15). Cuts
S9–11 at OriC are consistent with those previously deter-
mined by agarose gel electrophoresis [19] and illustrated
Figure 3. Heat maps showing the frequency of cuts on the luciferase pDNA resulting from the S1 nuclease digest in water. White color
indicates that the percentage of plasmids cut is between zero and the lower part of the cut range listed. Black color indicates that the
percentage cut is the maximum value for that cut range. Greyscale indicates cut percentages between these extrema. (A) The full
range of labile sites. (B) Labile regions that have frequency of cuts between 25% and 45% (showing approximately 15 of the most
cut regions). (C) Approximately top 5 of the cut regions between 28% and 45%. The luciferase functional map is provided in registry
with the heat map to facilitate comparison of cuts sites to the different regions of the plasmid. CMVp, CMV immediate early enhancer/
promoter; SVp, SV40 early enhancer/promoter.
Figure 4. Heat maps showing frequency of cuts on the luciferase plasmid resulting from cytosolic nuclease treatments. White color
indicates the percentage of cut is between zero and the lower part of the cut range listed. Black color indicates the percentage of
cut is the maximum value for that cut range. Greyscale indicates cut percentages between these extrema. (A–C) Labile cut regions
for G5 polyplex-treated cell cytosol treatment. (A) The full range of labile sites. (B) Labile regions that have a frequency of cuts be-
tween 41% and 65% (showing approximately 15 of the most cut regions). (C) Approximately top 5 of the cut regions between 52%
and 65%. (D–F) Cells-only cytosol treatment. (D) The full range of labile sites. (E) Labile regions that have a frequency of cuts between
50% and 75% (showing approximately 15 of the most cut regions). (F) Approximately top 5 of the cut regions between 59% and 75%.
CMVp, CMV immediate early enhancer/promoter; SVp, SV40 early enhancer/promoter.
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in Figure 1. The homopurine/homopyrimidine rich sites
like poly(A) and OriC have been reported as susceptible
to S1 nucleases using gel electrophoresis [19,22]; how-
ever, using high-throughput sequencing, we have found
many additional labile regions not previously identiﬁed.
These ﬁndings call into question the long held hypothesis
that S1 nuclease only attacks single-stranded secondary
structures of DNA because many of the cleaved regions
are considered to maintain a double-stranded DNA
(dsDNA) structure [18,19,22]. Alternatively, if S1 nucle-
ase is only active against single-stranded DNA, these data
indicate regions of substantial structural ﬂuxionality in
regions generally considered to maintain a dsDNA structure.
Figure 4 illustrates the activity of cytosolic nucleases
overlaid on the luciferase pDNA functional map.
Figures 4A to 4C provide data for nuclease activity from
cytosol obtained for cells treated with G5 polyplexes. In
a previous study, we demonstrated that nuclease activity
is polyplex dependent and is negatively related to the
level of protein expression [17]. G5 polyplexes were
selected because they induced the maximum level of nu-
clease activity and gave the minimum level of expression.
We also prepared lysates from cells that had not been
treated with polyplexes to establish the ‘background’ level
of nucleases. The data presented in Figures 4D to 4F,
although important and informative, must be treated with
caution when ascribing nuclease levels in a normal, func-
tional cell. Caveats include the neoplastic origin of HeLa
cancer cell line and also that the cytosol was obtained by
cell lysis, which is a procedure that may itself trigger
nuclease activity [23,24].
Figures 4A and 4D show all the labile sites present in
0–65% and 0–75% extent of cut range for the G5 polyplex-
treated and untreated cells, respectively. Similar to S1 nucle-
ase, the cytosolic nucleases are promiscuous and attack
numerous regions in addition to the most common cuts in
the poly(A) and viral enhancer/promoter regions of the
pDNA. Figures 4B and 4E represent the 15 most labile re-
gions lying in the range of 41–65% and 50–75% for G5
polyplex-treated and untreated cell cytosolic samples, respec-
tively. Figure 4C (52–65% extent of cut) and Figure 4F
(59–75% extent of cut) represent the most labile regions and
are most useful for comparison with gel electrophoresis data.
Table 2 summarizes the top 15 most labile regions
obtained with the cytosol from untreated cells (data in
Figure 4E). Cytosolic nucleases in this cytosol produce
four cuts in the viral cytomegalovirus (CMV) enhancer/
promoter region, one cut in the luciferase gene, three cuts
in the poly(A) regions, two cuts on OriC and three cuts on
the ampicillin gene. Table 3 shows the top 15 labile sites for
cytosol from G5 polyplex treated cells (data in Figure 4B).
Three cuts are observed in the viral enhancer/promoter re-
gions, one cut in the luciferase gene, two cuts in the poly
(A) sequence, two cuts near OriC, one cut in the ampicillin
resistance gene and one cut in the neomycin gene.
Cytosol nuclease activity from untreated cells and G5
polyplex treated cells display signiﬁcant similarities. The
top 15 labile regions for cytosolic samples can be divided
into three major regions: the viral promoter/enhancer se-
quence, poly(A) sequences and OriC. There are also some
cut regions in the luciferase reporter and the selective neo-
mycin resistance gene. Cuts in viral promoter/enhancers,
poly(A) sequences and the transgene can severely abro-
gate transgene expression [18,25]. The multiple cuts in
the selective neomycin and ampicillin resistance genes
point to the additional challenge in efforts to establish
the cell lines with stable plasmid expression. The bacterial
origin of replication (OriC) is necessary for plasmid repli-
cation in bacteria [26], although it has little functional role
in eukaryotes [27]. The discovery that OriC is one of the
most degraded regions for S1 (Table S1) and cytosolic nu-
cleases (Tables S2 and S3) suggests that eukaryotic cells
may recognize OriC as a marker for foreign DNA. In sum-
mary, we have detected a greater number of labile regions
Table 1. Summary of the top 15 regions of the luciferase plasmid cut by S1 nuclease, as shown in Figure 3B.
Region Percentage AT content Function Cut location and width (bp) Percentage extent of cut (average, maximum)
S1 43 Luciferase gene 1142–1187 (46) 29, 33
S2 50 ’’ 2042–2067 (26) 26, 27
S3 36 ’’ 2195–2217 (22) 27, 29
S4 25 ’’ 2292–2319 (28) 28, 30
S5 55 SV40 promoter 2903–2913 (11) 25, 26
S6 39 Neomycin gene 3261–3296 (36) 27, 29
S7 32 ’’ 3489–3544 (56) 28, 29
S8 38 ’’ 3967–4018 (52) 27, 29
S9 53 OriC 4474–4484 (15) 26, 26
S10 54 ’’ 4812–4910 (99) 31, 41
S11 78 ’’ 4974–4990 (17) 35, 38
S12 48 Close to OriC 5062–5076 (14) 25, 26
S13 67 Ampicillin gene 5116–5145 (30) 27, 29
S14 47 ’’ 5283–5325 (43) 26, 28
S15 53 ’’ 5725–5741 (17) 26, 28
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susceptible to cleavage for cytosolic extracts than for S1
nuclease exposure. The greater number of cleaved regions
likely arises from the presence of a number of different
mammalian nucleases being present in the cytosol, al-
though we cannot rule out the presence of a single class
of nuclease that are simply less selective.
In other studies, treatment with G5 PAMAM polyplexes
lead to the highest cytosolic nuclease activation leading to
a decrease in transgene expression [17]. Figure 5 shows
that G5 PAMAM polyplex treated cell cytosol has activity
similar to control cell cytosol with several notable, and
possibly signiﬁcant differences, especially in the luciferase
transgene. The labile region in the luciferase gene is one
of the top 15 most labile regions for G5 polyplex treated
cytosol; however, this is not the case for untreated cells
cytosol. This may contribute to poor luciferase transgene
expression facilitated by G5 PAMAM polyplexes. This is
consistent with the hypothesis that G5 PAMAM polyplexes
induce heightened activation of cytosolic nuclease, there-
fore decreasing the transgene expression [17]. When
making this comparison, it is important to note that all
cells were lysed for the sequencing experiments, which
may lead to changes in the activity of cytosolic nucleases.
No consensus cleavage sequence was
identiﬁed
Apart from showing the position of labile sites, sequencing
also provides a unique opportunity to evaluate homology
between the labile sites. To study and quantify homology
between the labile sequence for S1 and cytosolic sample,
we attempted to develop a consensus sequence by
performing a multiple sequence alignment of the most
labile region of the cytosolic samples and the S1 nuclease
sample (S10, C9, G13 in Tables 1, 2 and 3, respectively).
The best consensus sequence identiﬁed, AGCTCTTGA-
TCCGGCAAACAAACCACC, was then used to calculate sim-
ilarity for other labile sequence locations. Tables S3, S4, and
S5 show the analyses performed for S1 nuclease, control
Table 3. Summary of the top 15 regions of the luciferase plasmid cut by G5 polyplex-treated cells cytosolic nucleases (as shown in
Figure 4B).
Region Percentage AT content Function Cut location and width (bp) Percentage extent of cut (average, maximum)
G1 57 CMV promoter 4 to 33 (37) 45, 49
G2 83 ’’ 38–55 (18) 42, 44
G3 37 ’’ 141–148 (8) 41, 42
G4 75 ’’ 150–181 (32) 41, 45
G5 56 Luciferase gene 1738–1764 (27) 44, 48
G6 73 SV40 poly(A) 2610–2686 (71) 45, 55
G7 54 SV40 promoter 2827–2850 (24) 42, 44
G8 25 ’’ 3002–3005 (4) 42, 44
G9 47 ’’ 3083–3156 (74) 48, 54
G10 33 Neomycin gene 3947–3949 (3) 41, 41
G11 33 Close to OriC 4359–4361 (3) 41, 41
G12 48 OriC 4748–4797 (50) 43, 48
G13 59 ’’ 4882–5182 (300) 47, 59
G14 51 Ampicillin gene 6051–6109 (51) 44, 49
G15 72 Synthetic poly(A) 6208–6275 (60) 52, 61
Table 2. Summary of the top 15 regions of the luciferase plasmid cut by cells only cytosolic nucleases (as shown in Figure 4E).
Region Percentage AT content Function Cut location and width (bp) Percentage extent of cut (average, maximum)
C1 67 CMV promoter 62–113 (52) 51, 53
C2 57 ’’ 321–327 (7) 51, 53
C3 50 Luciferase gene 2483–2520 (38) 55, 63
C4 62 SV40 poly(A) 2573–2580 (8) 51, 53
C5 73 ’’ 2633–2683 (51) 53, 57
C6 62 SV40 promoter 2831–2859 (29) 52, 54
C7 44 ’’ 3081–3160 (80) 58, 61
C8 45 OriC 4774–4804 (31) 58, 61
C9 50 ’’ 4915–5022 (103) 58, 71
C10 50 Close to OriC 5060–5063 (4) 52, 53
C11 62 ’’ 5075–5126 (52) 51, 56
C12 86 Ampicillin gene 5148–5196 (49) 57, 62
C13 58 ’’ 5991–6002 (12) 52, 55
C14 42 ’’ 6025–6066 (42) 54, 57
C15 70 Synthetic poly(A) 6217–6273 (57) 54, 59
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cytoplasm and the G5 polyplex treated cells cytoplasm sam-
ples, respectively. This analysis shows that there exists very
low sequence homology between the best identiﬁed ‘con-
sensus sequence’ and labile regions for S1 nuclease and cy-
tosolic samples. The lack of a consensus sequence for the
cleavage locations supports the hypothesis that nucleases
are not primary DNA sequence speciﬁc, and can be consid-
ered promiscuous with respect to the base pair sequence.
Conclusions
Agarose gel electrophoresis and Illumina dye sequencing
conﬁrm that cytosolic nucleases cleave luciferase pDNA,
rendering it a nonfunctional template for expression,
and that S1 nuclease cuts at high homopurine/
homopyrimidine regions of the plasmid [18,19]. To the
best of our knowledge, this is the ﬁrst time high-throughput
sequencing has been used to study degradation effects of S1
and cytosolic nucleases on pDNA. Interestingly, the most
susceptible cut region for S1 nuclease overlaps the suscepti-
ble region for cytosolic nucleases, consistent with the
hypothesis that S1 type nucleases are part of the cytosolic
nuclease milieu. Lack of signiﬁcant homology between
labile sequences and a consensus sequence suggests that
these nucleases are highly promiscuous. In addition, our
agarose gel results are consistent with the hypothesis that
S1 and cytosolic nucleases are more likely to cleave
supercoiled pDNA than the linear form of DNA. Our data
further indicates that, because many of susceptible sites
lie in the indispensible functional units of pDNA, there
is a limit to DNA sequence optimization. To overcome this
challenge, further research is needed on polymers
designed to protect these labile regions from degradation
during the transport of pDNA into the cell and to
the nucleus.
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Figure S1. Circular plasmid map of pGL4.51.
Figure S2. Agarose gel electrophoresis comparing Luciferase plasmid digestion pattern for S1 nuclease with a known
nicking endonuclease (Nb.BtsI, two sites) and a known degradation nuclease (CviPII, > 500 sites). Lanes 1 and (6)
10-kb DNA ladder. Lane (2) pDNA in water. Lane (3) pDNA treated with 0.2 units of S1 nuclease. Lane (4) pDNA
treated with 1.0 unit of Nb.BtsI. Lane (5) pDNA treated with 1.0 unit of CviPII. 0.2μg pDNA used for all lanes. Endo-
nuclease treatments performed with supplied buffers for 1 h at 37°C. To prove the band appearing at approximately
10 kb is a nicked plasmid arising from the luciferase pDNA, we performed digestions with Nb.BtsI, a nicking endonu-
clease that acts at two locations, and CviPII endonuclease that nicks at >500 locations leading to complete digestion
of the plasmid. The S1 nuclease results in three bands, including the nicked plasmid at approximately 10 kb as observed
in Fig. 1. Treatment with the Nb.BtsI yields only the nicked plasmid at approximately 10 kb. Treatment with CviPII de-
grades the pDNA into <500-bp fragments. The total amount of signal at the 10-kb band location increase by approxi-
mately 10% upon treatment with S1 nuclease and approximately 45% upon treatment with Nb.BtsI. The sum of these
data is consistent with assignment of the 10-kb band as nicked plasmid.
Table S1. Top 20 most cut sites for S1 nuclease in luciferase plasmid. S10_X represents the cut site belonging to the S10
region from Table S1.
Table S2. Top 20 most cut sites for S1 nuclease in luciferase plasmid. C9_X represents the cut site belonging to the C9
region from Table S3.
Table S3. Top 20 most cut sites for G5 polyplex treated cells cytosolic nuclease. G15_X and G13_X represents the cut
site belonging to the G15 and G13 regions, respectively, from Table S5.
Table S4. S1 nuclease treatment: pairwise alignment using consensus sequence.
Table S5. Cytoplasmic extract from HeLa cells only treatment: pairwise alignment using consensus sequence.
Table S6. Cytoplasmic extract from G5 polyplex HeLa cells treatment: pairwise alignment using consensus sequence.
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